Background: Among all complications of systemic sclerosis, interstitial lung disease (ILD) is the most common complication with poor prognosis and limited clinical treatment options. In SSc, T helper 2 cells perform as important pathogenic factors, and inducible co-stimulator (ICOS) participate in Th2 differentiation and selective IL-4 expression. However, the identity of the relevant ICOS⁺ Th2 cells and their contribution to inflammation and fibrosis in SSc are still unknown. Objectives: This study aims to investigate the function and clinical significance of a new subgroup of Th2 cells in SSc. Methods: The leukocyte landscape of PBMCs from SSc patients and healthy controls was mapped using mass cytometry (cytometry by time-of-flight detection [CyTOF]). Flow cytometry analyses of human PBMCs were conducted to examine CD4⁺CXCR5⁻ICOS⁺IL-4⁺ cells. Human lung fibroblasts were cocultured with differentiated CD4⁺ICOS⁺IL-4⁺ cells and then were tested for their mRNA expression of fibrotic factors. SSc-ILD model was conducted by tracheal instillation of bleomycin. And the frequency of CD4⁺CXCR5⁻ICOS⁺IL-4⁺ cells were tested in lung, spleen and peripheral blood. Rag-deficient mice was injected with in vitro differentiated CD4⁺ICOS⁺IL-4⁺ cells and pulmonary inflammation and fibrosis were evaluated by Masson and HE staining. Results: A group of CD4⁺CCR4⁺ICOS⁺ T cells were screened through CyTOF and significantly increased in SSc-ILD patients. This subset was defined as ICOS+Th2 cells, as they didn't express biomarkers of Tfh cells (CXCR5), Th1 cells (CXCR3), and Th17 cells (CCR6). And besides, CCR4 is preferentially expressed on Th2 cells. A significantly higher frequency of CD4⁺CXCR5⁻ICOS⁺IL-4⁺ T cells, most of which (~90%) were CCR4⁺ T cells, in peripheral blood of SSc-ILD patients could also be detected by flow cytometry. Futhermore, the upregulated frequency of CD4⁺CXCR5⁻ICOS⁺IL-4⁺ T cell were also found in the lung and spleen of BLM-induced pulmonary fibrosis mice model. In vitro, human lung fibroblasts could be differentiated to α-SMA⁺myofibroblasts and product more collagen after being cocultured with differentiated CD4⁺ICOS⁺IL-4⁺ T cells (ICOS⁺ Th2 cells). In vivo, differentiated ICOS⁺ Th2 cells, which were injected into Rag-deficient mice, could induce pulmonary inflammation and fibrosis. Conclusion: Our results together demonstrated the positive expression for the ICOS on Th2 cells, and provide functional evidence that ICOS⁺ Th2 cells could mediating to SSc-ILD by secreting IL-4. REFERENCES: NIL. Acknowledgements: NIL. Disclosure of Interests: None declared.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: